$30.99
+0 (+0%)
At Close: Jun 16, 2026
Confluent Health Launches The Pain Perspective, Revealing a New National Portrait of Chronic Pain in America
09:00am, Tuesday, 16'th Jun 2026
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest
Confluent Makes It Easier to Build and Secure Real-Time AI at Scale
05:00am, Tuesday, 19'th May 2026
LONDON--(BUSINESS WIRE)--Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artifici
Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
12:30pm, Friday, 01'st May 2026
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Confluent, Inc. – CFLT
05:16pm, Tuesday, 21'st Apr 2026
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
10:00am, Thursday, 16'th Apr 2026
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
04:44pm, Tuesday, 14'th Apr 2026
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors a
IBM set for in-line Q1 as Confluent deal boosts outlook
03:45pm, Monday, 13'th Apr 2026
International Business Machines Corp (NYSE:IBM) is expected to report first-quarter results largely in line with forecasts on April 22, but Bank of America is adjusting estimates following the earlier
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
05:20pm, Tuesday, 07'th Apr 2026
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors a
Capricorn Fund Managers Ltd Buys New Stake in Confluent, Inc. $CFLT
04:43am, Monday, 06'th Apr 2026
Capricorn Fund Managers Ltd purchased a new position in shares of Confluent, Inc. (NASDAQ: CFLT) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
10:00am, Thursday, 02'nd Apr 2026
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
06:41pm, Tuesday, 31'st Mar 2026
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
10:00am, Thursday, 26'th Mar 2026
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised t
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
04:52pm, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are a
Confluent, Inc. (NASDAQ:CFLT) Receives Consensus Recommendation of “Hold” from Brokerages
02:31am, Sunday, 22'nd Mar 2026
Confluent, Inc. (NASDAQ: CFLT - Get Free Report) has been assigned an average rating of "Hold" from the thirty-three brokerages that are presently covering the firm, MarketBeat.com reports. One invest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
09:54pm, Thursday, 19'th Mar 2026
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to
Sign In
Buy CFLT